Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
276.5 GBX | +6.35% | +28.60% | +25.68% |
Apr. 29 | FTSE 100 as investors look to Fed rate decision | AN |
Apr. 29 | Transcript : Oxford Biomedica plc, Q4 2023 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.68% | 326M | |
-3.56% | 102B | |
+1.43% | 96.29B | |
+2.13% | 22.18B | |
-15.88% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.65% | 16.36B | |
+4.30% | 13.97B | |
+31.41% | 12.17B |
- Stock Market
- Equities
- OXB Stock
- News Oxford Biomedica plc
- EnSilica Appoints Oxford Biomedica Executive as CFO